Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro - PubMed (original) (raw)
Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro
A Yamaguchi et al. J Cell Biol. 1991 May.
Abstract
The in vitro effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on osteogenic and myogenic differentiation was examined in two clonal cell lines of rat osteoblast-like cells at different differentiation stages, ROB-C26 (C26) and ROB-C20 (C20). The C26 is a potential osteoblast precursor cell line that is also capable of differentiating into muscle cells and adipocytes; the C20 is a more differentiated osteoblastic cell line. Proliferation was stimulated by rhBMP-2 in C26 cells, but inhibited in C20 cells. rhBMP-2 greatly increased alkaline phosphate (ALP) activity in C26 cells, but not in C20 cells. The steady-state level of ALP mRNA was also increased by rhBMP-2 in C26 cells, but not in C20 cells. Production of 3',5'-cAMP in response to parathyroid hormone (PTH) was dose-dependently enhanced by adding rhBMP-2 in both C26 and C20 cells, though the stimulatory effect was much greater in the former. There was neither basal expression of osteocalcin mRNA nor its protein synthesis in C26 cells, but they were strikingly induced by rhBMP-2 in the presence of 1 alpha,25-dihydroxyvitamin D3. rhBMP-2 induced no appreciable changes in procollagen mRNA levels of type I and type III in the two cell lines. Differentiation of C26 cells into myotubes was greatly inhibited by adding rhBMP-2. The inhibitory effect of rhBMP-2 on myogenic differentiation was also observed in clonal rat skeletal myoblasts (L6). Like BMP-2, TGF-beta 1 inhibited myogenic differentiation. However, unlike BMP-2, TGF-beta 1 decreased ALP activity in both C26 and C20 cells. TGF-beta 1 induced neither PTH responsiveness nor osteocalcin production in C26 cells, but it increased PTH responsiveness in C20 cells. These results clearly indicate that rhBMP-2 is involved, at least in vitro, not only in inducing differentiation of osteoblast precursor cells into more mature osteoblast-like cells, but also in inhibiting myogenic differentiation.
Similar articles
- Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Katagiri T, et al. J Cell Biol. 1994 Dec;127(6 Pt 1):1755-66. doi: 10.1083/jcb.127.6.1755. J Cell Biol. 1994. PMID: 7798324 Free PMC article. - Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament.
Kobayashi M, Takiguchi T, Suzuki R, Yamaguchi A, Deguchi K, Shionome M, Miyazawa Y, Nishihara T, Nagumo M, Hasegawa K. Kobayashi M, et al. J Dent Res. 1999 Oct;78(10):1624-33. doi: 10.1177/00220345990780100701. J Dent Res. 1999. PMID: 10520967 - Effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of decorin and biglycan by cultured osteoblastic cells.
Takagi M, Yamada T, Kamiya N, Kumagai T, Yamaguchi A. Takagi M, et al. Histochem J. 1999 Jun;31(6):403-9. doi: 10.1023/a:1003704425809. Histochem J. 1999. PMID: 10462226 - Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily.
Yamaguchi A. Yamaguchi A. Semin Cell Biol. 1995 Jun;6(3):165-73. doi: 10.1006/scel.1995.0023. Semin Cell Biol. 1995. PMID: 7548856 Review. - Polypeptide growth factors in bone matrix.
Hauschka PV, Chen TL, Mavrakos AE. Hauschka PV, et al. Ciba Found Symp. 1988;136:207-25. doi: 10.1002/9780470513637.ch13. Ciba Found Symp. 1988. PMID: 3068010 Review.
Cited by
- Unlocking the potential of stimuli-responsive biomaterials for bone regeneration.
Yang K, Wu Z, Zhang K, Weir MD, Xu HHK, Cheng L, Huang X, Zhou W. Yang K, et al. Front Pharmacol. 2024 Jul 31;15:1437457. doi: 10.3389/fphar.2024.1437457. eCollection 2024. Front Pharmacol. 2024. PMID: 39144636 Free PMC article. Review. - Towards an enhanced understanding of osteoanabolic effects of PTH-induced microRNAs on osteoblasts using a bioinformatic approach.
Vrščaj LA, Marc J, Ostanek B. Vrščaj LA, et al. Front Endocrinol (Lausanne). 2024 Jul 17;15:1380013. doi: 10.3389/fendo.2024.1380013. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39086902 Free PMC article. - Regulating the bioactivity of non-glycosylated recombinant human bone morphogenetic protein-2 to enhance bone regeneration.
Yu Y, Chen R, Chen X, Wang J, Liu C. Yu Y, et al. Bioact Mater. 2024 Apr 30;38:169-180. doi: 10.1016/j.bioactmat.2024.04.018. eCollection 2024 Aug. Bioact Mater. 2024. PMID: 38711759 Free PMC article. - Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification.
Juan C, Bancroft AC, Choi JH, Nunez JH, Pagani CA, Lin YS, Hsiao EC, Levi B. Juan C, et al. Biomolecules. 2024 Mar 14;14(3):349. doi: 10.3390/biom14030349. Biomolecules. 2024. PMID: 38540768 Free PMC article. Review. - The polymer and materials science of the bacterial fimbriae Caf1.
Fulton DA, Dura G, Peters DT. Fulton DA, et al. Biomater Sci. 2023 Nov 7;11(22):7229-7246. doi: 10.1039/d3bm01075a. Biomater Sci. 2023. PMID: 37791425 Free PMC article. Review.
References
- J Cell Biol. 1987 Apr;104(4):1077-84 - PubMed
- Biochem Biophys Res Commun. 1986 Oct 15;140(1):56-65 - PubMed
- J Biol Chem. 1990 Aug 5;265(22):13198-205 - PubMed
- EMBO J. 1990 Jul;9(7):2085-93 - PubMed
- Proc Natl Acad Sci U S A. 1990 Mar;87(6):2220-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials